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Clinical hematopoietic transplantation outcomes are
strongly correlated with the numbers of cells infused.
Anticipated novel therapeutic implementations of
hematopoietic stem cells (HSCs) and their deriva-
tives further increase interest in strategies to expand
HSCs ex vivo. A fundamental limitation in all HSC-
driven culture systems is the rapid generation of
differentiating cells and their secreted inhibitory
feedback signals. Herein we describe an integrated
computational and experimental strategy that en-
ables a tunable reduction in the global levels and
impact of paracrine signaling factors in an automated
closed-system process by employing a controlled
fed-batch media dilution approach. Application of
this system to human cord blood cells yielded a rapid
(12-day) 11-fold increase of HSCswith self-renewing,
multilineage repopulating ability. These results high-
light the marked improvements that control of feed-
back signaling can offer primary stem cell culture
and demonstrate a clinically relevant rapid and rela-
tively low culture volume strategy for ex vivo HSC
expansion.
INTRODUCTION
Emerging data suggest that robustness and responsiveness in
hematopoiesis is a property of the system, not an individual
cell. The hematopoietic system is able to dynamically maintain
appropriate proportions of cells of all hematopoietic lineages
throughout the lifetime of the individual, both during homeo-
stasis and in response to regenerative demand. This regulation
depends on intercellular (between cell) communication net-
works, resulting from both local and systemic factor secretion218 Cell Stem Cell 10, 218–229, February 3, 2012 ª2012 Elsevier Inc(Kirouac et al., 2010). Hematopoietic stem cells (HSCs) must
respond to and integrate cues from the microenvironment to
ensure sustained production of all hematopoietic lineages
(Rizo et al., 2006). As such, self-renewal versus differentiation
decisions of HSCs critically depend on feedback-mediated
paracrine factors and the associated signaling networks, both
in vivo and in vitro.
Several decades of successful bone marrow transplantations
have demonstrated the therapeutic importance of HSCs. The
use of noninvasively accessible umbilical cord blood (UCB)-
derived HSCs provides many advantages over bone marrow,
including enhanced long-term immune recovery and decreased
graft versus host disease (Gluckman, 2009; Wagner and Gluck-
man, 2010). However, because clinical studies have indicated
that the most important factor for patient survival after UCB
transplantation is infusing a cell dose above a minimum
threshold of 33 107 cells/kg (Gluckman, 2009), low cell numbers
in single UCB units have limited the suitability of UCB transplan-
tation for adult patients. Methods to robustly increase the
number of cells that give a rapid and sustained blood count
recovery would enable the use of UCB in all patients (Hofmeister
et al., 2007).
Strategies to expand HSC numbers in vitro have focused on
identifying molecules that specifically target the stem cell popu-
lation. Recent data demonstrating that there are multiple
subpopulations of HSCs and that these cells are molecularly
closely related (Benveniste et al., 2010; Dykstra et al., 2007)
suggest that the opportunity of finding molecules that uniquely
expand the long-term HSC pool (Antonchuk et al., 2002; Boitano
et al., 2010; Delaney et al., 2010; Durand and Zon, 2010; Zhang
et al., 2008) without impacting the distribution and growth of
their more restricted progeny is challenging, especially after
extended periods of time in culture. Herein we propose a funda-
mentally different and complementary approach, examining the
impact of feedback signaling control on HSC output.
Feedback control is complicated by the fact that the hemato-
poietic system is regulated by a complex hierarchy of cellular
and molecular networks. We have previously performed cell-cell.
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the mode of action of endogenously produced HSC-inhibitory
factors generated during in vitro UCB culture (Kirouac et al.,
2010). Recognition that large numbers of these factors are
produced in a time-dependent manner makes the addition of
binding and signaling inhibitors challenging. We sought to iden-
tify a strategy to globally control feedback regulation. We per-
formed computational simulations of in vitro hematopoiesis
and iteratively predicted and evaluated candidate strategies for
the reduction of endogenously produced negative regulators.
In silico optimization resulted in the identification and develop-
ment of a ‘‘fed-batch’’ culture strategy for HSC growth enhance-
ment. By linking dynamic cell growth and endogenous factor
secretion to a tunable media dilution algorithm, we experimen-
tally confirmed predictions of significant enhancements in
stem and progenitor growth, including an 80-fold increase in
CD34+ cells and an 11-fold increase in NOD.Cg-Prkdcscid
Il2rgtm1Wjl/SzJ (NSG) repopulating cells (detected at limiting
dilution after 16 weeks) within a 12-day culture period. Further-
more, this platform complements knownHSC-enhancing factors
and has provided insight into their mode of action. The integra-
tion of our strategy into an automated and closed-system
bioreactor has produced a clinically relevant system for HSC
expansion.RESULTS
In Silico Design of a ‘‘Fed-Batch’’ Media Dilution
Strategy
Hematopoietic culture systems generate a large number of
endogenously produced soluble factors as a result of the rapid
production of mature blood cells (Kirouac et al., 2010; Majka
et al., 2001; Sautois et al., 1997). In order to investigate the
impact of these secreted ligands, we first measured a sampling
of the secreted factor profile under our previously optimized
in vitro expansion conditions (Madlambayan et al., 2005) and
found the rapid accumulation of many physiologically relevant
ligands and large fluctuations resulting from periodic media
exchanges (Figure 1A). Many of these factors have been re-
ported to have inhibitory effects on human hematopoietic stem
and progenitor cell expansion (Bonnet et al., 1995; Broxmeyer
et al., 1995; Broxmeyer and Kim, 1999; Cashman et al., 1998;
Fortunel et al., 2000; Zhang et al., 1995), and our previous
studies have validated that several factors which are present at
high levels in the culture system have a significant inhibitory
effect on hematopoietic progenitor expansion, including TGF-b,
MCP-1 (CCL2), MIP-1a (CCL3), MIP-1b (CCL4), and IP-10
(CXCL10) (Kirouac et al., 2010).
The large number and nonlinear nature of the secreted factor
profiles limit the likely success of using molecularly targeted
approaches to reduce the inhibitory impact of these factors
and, instead, necessitates a global and unbiased strategy for
feedback regulation. In order to identify and optimize an appro-
priate strategy, we performed computational simulations of cell
population dynamics to investigate and predict the effect of
candidate culture manipulations. Our computational approach
(Kirouac et al., 2009) incorporated the effect of feedback
signaling from differentiated cells on stem and progenitor cellCeexpansion. This feedback is coded through different classes of
paracrine signaling loops, as depicted in Figure 1B.
As a first step, we explored in silico strategies of regulating the
effective concentration of the different classes (SF1–SF4) of
secreted ligands. Under baseline conditions, with a full media
exchange every 4 days, simulations depict a predominant
accumulation of inhibitory factors (SF1 and SF2) (Figure 1C).
As such, a net increase in stem and progenitor proliferation
was predicted to result from minimizing the entire set of
endogenously produced ligands. Rationalizing that the fre-
quency of conditioned media removal would be an important
parameter (Madlambayan et al., 2005), we first compared the
effects of frequent full or partial media exchanges with our
control culture process. The model predicted that a full media
exchange every day (Figure 1D) or a half media exchange every
12 hr (Figure 1E) would outperform less frequent exchanges,
emphasizing the importance of strong and frequent secreted
factor regulation.
To limit periodic fluctuations and intermittent exposure to high
concentrations of secreted ligands and to attain a continuous
and tunable mode of media regulation, we simulated the effects
of perfusion and fed-batch culture systems. A perfusion system
(Figure 1F) is characterized by a continuous input of fresh media
and output of spent media, while maintaining a constant
volume,whereasa fed-batchsystem (Figure1G)containsan input
stream only, resulting in a continuous increase in culture
volume.Thesecell culture systemsarecommonlyusedas feeding
strategies for biopharmaceutical production (Farid, 2006), and
previous studies have explored the use of perfusion systems for
HSC culture (Koller et al., 1998). Simulations predicted that
a fed-batch media dilution approach would achieve the most
effective enhancement in stem and progenitor expansion and
was predicted to outperform perfusion cultures and frequent
media exchange strategies (Figures 1C–1G). Although all strate-
gies act by reducing the concentration of accumulating secreted
factors, the increasing culture volume of the fed-batch strategy
additionally maintains lower cell densities, thereby slowing the
rate and impact of endogenous factor accumulation.
The dilution rate (D) of a fed-batch culture system is defined as
the input flow rate divided by the culture volume. This rate can be
constant throughout the reaction period, proportional to the
current volume of the culture or tuned based on predicted or
measured parameters. As shown in Figure 1H, the volume of
a culture initially containing 1 ml, will increase continuously
with time depending on the defined dilution rate. Simulations
predicted that the dilution rate would regulate the concentration
of all secreted factors (Figure 1I), which in turn would regulate
expansions of total nucleated cells (TNCs), colony-forming cells
(CFCs), long-term culture-initiating cells (LTC-ICs), and SCID
repopulating cells (SRCs) (Figure 1J). The slopes of the predicted
increases in expansions are greatest from D = 0 to D = 1, sug-
gesting that a significant impact on HSC expansion should
be achievable at moderate dilution rates, while maintaining
moderate media and cytokine needs.
Automated Closed System Fed-Batch Culture Enhances
Progenitor Cell Expansion
We next undertook experiments to test the predicted superiority
of the in silico optimized fed-batch strategy. These studies werell Stem Cell 10, 218–229, February 3, 2012 ª2012 Elsevier Inc. 219
Figure 1. Computational Simulations Predict a Fed-Batch Strategy, at Moderate Dilution Rates, to Greatly Reduce Secreted Factor Concen-
trations and Give a Significant Enhancement of Expansion
(A) Time course of experimentally measured secreted factor concentrations from UCB culture, with complete media exchange every 4 days.
(B) Schematic ofmathematicalmodel, indicating the presence of paracrine feedback signaling. Groups of secreted factors are categorized depending onwhether
they act in a stimulatory or inhibitory manner and whether they impact stem cell self-renewal or proliferation.
(C–G) Simulated volume, secreted factor concentrations, and relative expansions under different media manipulation strategies: (C) ‘‘control’’ culture with com-
plete media exchange (ME) every 4 days; (D) culture with complete media exchange every 24 hr; (E) culture with 50%media exchange every 12 hr; (F) perfusion
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Figure 2. The Fed-Batch Strategy Is Experimentally Validated In Vitro to Give Significantly Improved Expansion of Progenitor Cells
(A) Schematic of experimental set-up comparing control (D = 0) strategy with 100% media exchange (ME) every 4 days to fed-batch (D = 1) strategy.
(B) Expansions of TNC, CFC, and LTC-IC, after 12 days of culture. n > 5.
(C) (i, iii) Surface marker analysis of CD34+ and CD133+CD38 frequencies throughout in vitro culture. (ii, iv) Expansion of CD34+ cells and CD133+CD38 cells,
accounting for total cell expansion. n > 5.
(D) Normalized expansion of TNC, CFC, and LTC-IC after 12 days of culture, dependent on dilution rate. n = 3.
Data are expressed as mean ± SD. See also Figures S1 and S2.
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(Csaszar et al., 2009). This system allows the user to control
media input flow rates and enables the entire culture process
to be performed in a closed system with minimal manual inter-
vention. A constant flow rate, corresponding to a dilution rate
of D = 1, was compared to our previously described optimal
culture strategy (Madlambayan et al., 2005) (referred to here as
D = 0) (Figure 2A).
We first confirmed that the D = 1 fed-batch strategy signifi-
cantly outperformed the D = 0 control at our previously optimal
day 8 endpoint (Figure S1). We next computationally predicted
that the D = 1 strategy would achievemaximum expansions after
12 days of in vitro culture, because the regulation strategyculture with one unit of media perfused every 24 hr; (G) fed-batch culture with one u
and cytokine requirements (one additional unit of media every 24 hr).
(H) Media volume requirements for a fed-batch culture at different constant dilut
(I) Predicted effect of increasing constant dilution rate of fed-batch strategy on s
(J) Predicted effect of increasing constant dilution rate of fed-batch strategy on p
Ceinherent in the fed-batch system would allow for a positive rate
of expansion to be maintained for a greater length of time (Fig-
ure S1). As shown in Figure 2B, the D = 1 strategy reached
12-day expansions of 179-fold (range 105- to 344-fold) of
TNCs, 64-fold (22- to 166-fold) of CFCs, and 29-fold (14- to
53-fold) of LTC-ICs. Phenotypic analysis by flow cytometry (Fig-
ure 2C) indicated that the percentage of progenitor cells as
measured by CD34+ and CD133+CD38 remained unchanged
between the D = 0 and D = 1 cultures. However, the increased
total cell expansion with the D = 1 strategy led to a significant
increase in the absolute numbers of CD34+ cells (80-fold) and
CD133+CD38 cells (135-fold). Similar results were found with
CD34+CD90+ and CD34+CD49fhi cells (Figure S1).nit of media added every 24 hr. Conditions (D–G) are normalized to samemedia
ion rates, assuming a 1 ml initial volume.
ecreted factor concentrations.
opulation expansions.
ll Stem Cell 10, 218–229, February 3, 2012 ª2012 Elsevier Inc. 221
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fed-batch strategy to alternative strategies for the reduction of
endogenously produced factors by investigating frequent media
exchange approaches (Figure S2). Although small apparent
improvements over the D = 0 cultures were achieved with
frequent feeding strategies, these strategies produced signifi-
cantly lower expansions than the D = 1 strategy, despite having
the same overall media usage. We also assessed the effect of
varying the dilution rate of the fed-batch culture. As predicted,
the rate of increased expansion began to slow at dilution rates
greater than D = 1, leading to diminishing returns of cell expan-
sion at the expense of rapidly increasing media needs (Fig-
ure 2D). Taken together, these findings confirm our computa-
tional predictions of enhanced progenitor expansion achieved
with a robust media dilution approach.
Global Maintenance of Subthreshold Levels of Inhibitory
Factors Enables Fed-Batch-Mediated Expansion
of Primitive UCB Cells
The observed enhancement in progenitor expansion was pre-
dicted to result from a global reduction in inhibitory paracrine
factor levels in the culture media. To test this hypothesis, we
investigated the effect of the fed-batch strategy on the output
of specific mature blood cell types. Analysis of hematopoietic
cell lineage markers did not reveal any change in the relative
frequency of any of the differentiated cell types assessed
(CD14+, CD7+, CD41+, GyA+, CD33+, CD19+, CD56+, CD8+,
CD4+) with the D = 1 strategy, as compared to the D = 0 control.
Although the absolute number of cells in each of these popula-
tions was greater with the D = 1 strategy, resulting from the
enhanced TNC expansion, the lower cell densities achieved
with the D = 1 strategy resulted in lower concentrations (cells/ml)
of each mature cell population (Figure S3).
We next asked how the reduction in mature cell concentra-
tions would impact soluble factor concentrations. Figure 3A
depicts the degree by which the concentration of each mea-
sured soluble factor was changed with the D = 1 strategy, as
compared to D = 0. The nonlinear nature of factor accumulation
means that the dynamics of individual factors and the degree
by which the fed-batch strategy affects the concentration
of specific factors varies; however, the net global reduction
in factor concentrations provides an overall minimization of
feedback inhibition in the culture system. Figure 3B highlights
the concentration dynamics for several factors known to
impact stem and progenitor growth, demonstrating the reduc-
tion of ligand concentrations achieved with the fed-batch
strategy.
The functional effect of secreted ligand reduction on cell
growth was further tested by culturing cells in media that had
been previously conditioned for 8 days in a culture maintained
with either the D = 0 or the D = 1 strategy. Exogenous cytokines
(SCF, FL, TPO) were added to the conditioned media to ensure
that the difference between the fresh and conditioned media
was the presence of endogenously produced soluble factors.
Both conditioned media led to a significant reduction in TNC
expansions as compared to cultures utilizing fresh media, as
expected. However, the expansion achieved with the D = 1
conditioned media were significantly greater than with the
D = 0 conditioned media (Figure 3C). This shows the ability of222 Cell Stem Cell 10, 218–229, February 3, 2012 ª2012 Elsevier Increduced endogenous factor concentrations to better sustain
primitive UCB cells in culture.
It remained unclear whether the fed-batch strategy was acting
by simply regulating one or a few key inhibitory ligands or
whether a more comprehensive (global) manipulation of the
culture environment was important. To test this directly, we
compared the D = 1 strategy to the targeted inhibition of
TGF-b1, a known endogenous inhibitor of HSC growth (Fortunel
et al., 2000). Targeted inhibition of TGF-b1 was achieved by add-
ing the small molecule SB431542 to the culture every 4 days,
a manipulation that yielded increases in progenitor cell expan-
sions that approached those achieved by the fed-batch strategy
on day 8. However, after 12 days of culture, TGF-b1 inhibition no
longer had a significant effect on progenitor expansion (Fig-
ure 3D). This demonstrated that although some degree of culture
regulation could be initially provided through the inhibition of one
key endogenously produced factor, the impact of this approach
is limited, particularly at the later time points of culture when the
accumulation of many inhibitory factors is high, and targeting
one factor alone is no longer effective.
In previous studies (Kirouac et al., 2010), we used expression
analysis to identify 74 factors whose genes were upregulated
during UCB culture. Many of these factors were hypothesized
to be inhibitory to HSC growth and seven of these (TGF-b,
TNFSF9, MIP-1a, MIP-1b, IP-10, NAP-2, SPARC) were experi-
mentally validated to have an inhibitory effect on LTC-IC expan-
sion. To investigate whether these factors contribute to HSC
inhibition in an additive manner, we performed a combinatorial
analysis of inhibitory soluble factors on LinRholoCD34+
CD38CD45RACD49f+ cells, which have been reported to be
highly enriched for HSCs (Notta et al., 2011). The addition of
TGF-b1 (10 ng/ml), MIP-1a (100 ng/ml), MIP-1b (100 ng/ml),
and IP-10 (100 ng/ml) individually each caused a reduced expan-
sion of this population after 7 days of culture, and the simulta-
neous addition of these four inhibitors produced a significant
reduction of expansion, demonstrating that multiple inhibitory
factors present in the culture system act in an additive manner
(Figure 3E). Importantly, when lower concentrations (10 ng/ml
each) of MIP-1a, MIP-1b, and IP-10 were used, the effect of
the individual factors was negligible; however, the combination
of the three led to reduced cell expansions (Figure 3F). This study
illustrates how subthreshold levels of factors that individually
do not provide significant inhibition can produce an inhibitory
effect when acting in combination, highlighting the global nature
of feedback inhibition.
In order to rule out the possibility that the fed-batch strategy
was primarily acting by preventing critical metabolites from
becoming limiting and inhibiting cell growth (Collins et al.,
1997; Patel et al., 2000), we monitored the glucose and lactate
concentrations of the media. Glucose levels did not become
limiting under any of the culture conditions tested, including
the D = 0 control, as shown by the fact that glucose concentra-
tions below 7mMwere never observed (Figure S4). Furthermore,
when glucose was added to the D = 0 culture in order to
normalize the glucose levels to the corresponding D = 1 culture,
no effect on expansion levels was observed (Figure S4). Lactate
levels reached amaximum of 15mM in the D = 0 cultures and the
pH did not drop below 7.0, both of which were well within the
range that support normal hematopoietic cell proliferation.
Figure 3. The Fed-Batch Strategy Enhances Expansion through the Global Reduction of Endogenously Produced Inhibitory Secreted
Factors
(A) Heat map of secreted factor concentration ratios (D = 1/D = 0) showing the effect of the D = 1 strategy on secreted factor profiles as compared to the D = 0
strategy.
(B) Representative samples of reduction in secreted factor concentrations for: (i) TGF-b1; (ii) RANTES; (iii) IL-8; (iv) HGFwith the D = 1 strategy as compared to the
D = 0 strategy. n = 5.
(C) TNC expansion after 8 days of D = 0 culture with either fresh media or conditioned media (CM) from day 8 of previous D = 0 or D = 1 cultures. n = 3.
(D) Comparison of the fed-batch D = 1 strategy to the addition of a TGF-b1 small molecule inhibitor, SB431542, based on expansions of TNC, CFC, and LTC-IC at
(i) day 8 and (ii) day 12. n = 3.
(E) Inhibitory factors, TGF-b1 (10 ng/ml), MIP-1a (100 ng/ml), MIP-1b (100 ng/ml), and IP-10 (100 ng/ml) were added to a sorted HSC population
(LinRholoCD34+CD38CD45RACD49f+), and total cell expansion was assessed after 7 days of culture. n = 3.
(F) Low concentrations of inhibitory factors, MIP-1a (10 ng/ml), MIP-1b (10 ng/ml), and IP-10 (10 ng/ml) were added to a sorted HSC population
(LinRholoCD34+CD38CD45RACD49f+), and total cell expansion was assessed after 7 days of culture. n = 3.
Data are expressed as mean ± SD. See also Figures S3 and S4.
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the interpretation that the global reduction of inhibitory ligands
was providing the supportive conditions for improved progenitor
growth.
Transplantation Studies Show an 11-fold SRC
Expansion under Fed-Batch Conditions
To determine whether the enhanced expansions observed with
the progenitor populations would also apply to long-term repo-
pulating HSCs (LTR-HSCs), we performed transplantation
studies with the NSG mouse model (McDermott et al., 2010).
Repopulation was quantified by bonemarrow analysis for human
hematopoietic cell contribution 16 weeks after transplantation,
and freshly isolated (day 0) Lin UCB cells were compared to
cells cultured for 8 or 12 days. Figure 4A shows representative
flow cytometry plots of repopulated and nonrepopulated mice.
For each condition tested, a dose response of average human
contribution was seen, as determined by the quantification of
human CD45 and HLA-ABC double-positive populations
(Table S1).
All positively repopulated mice were found to have multiline-
age repopulation, as indicated by human cells that were positive
for a myeloid lineage marker (CD33), a B cell lymphoid lineage
marker (CD19), a T cell lineage marker (CD3), and an erythroid
lineage marker (GyA). Representative plots are shown in Figures
4B and 4C and full details are presented in Table S2. Human
progenitor cells were detected from 16-week transplanted
mice by both surface marker analysis (CD34+ and CD133+) and
CFC assays (Figures 4D and 4E). Cells from 8 mice repopulated
for 16 weeks with day 12 D = 1 cells (19%–62% human cells in
the marrow of primary recipients) were retransplanted into
secondary mice to determine whether the culture-expanded
cells had retained LTR-HSC activity. Five out of eight secondary
mice were positive for human cells (human contribution ranging
from 0.5% to 2.1%), all of which showed multilineage repopula-
tion (Table S3), indicating that the expanded cells are able to
maintain their long-term repopulation potential in vivo.
In order to quantify LTR-HSC expansion, limiting dilution anal-
yses were performed (Figure 4F). The frequency of LTR-HSCs in
the fresh Lin cells was 1 in 14,700 (95%CI: 1/8,659 to 1/24,979,
n = 26). After 8 days of culture, the D = 1 culture produced a cor-
rected LTR-HSC frequency of 1 in 1,940 (1 in 110,000 corrected
for the concomitant 57-fold expansion of TNCs, 95%CI: 1/1,195
to 1/3,149, n = 33), giving a 7.6-fold LTR-HSC expansion, relative
to the fresh cells. The D = 0 strategy gave a 3.6-fold LTR-HSC
expansion, as reported previously (Ito et al., 2010; Madlambayan
et al., 2005) (1 in 121,000 corrected for a 28-fold TNC expansion
to give a 1 in 4,330 corrected frequency, 95% CI: 1/2,223 to
1/8,428, n = 17). We predicted that the 12 day culture would
give the greatest LTR-HSC expansion, based on both computa-
tional simulations and progenitor assays. Indeed, the corrected
LTR-HSC frequency after 12 days of culture was 1 in 1,334 (after
a 1 in 233,000 frequency was corrected for 1783 total cell
expansion, 95% CI: 1/759 to 1/2,345, n = 24), producing an
11-fold LTR-HSC expansion. LTR-HSC frequencies were used
to determine SRC numbers per 106 cells (Figure 4G).
Collectively, these results demonstrate that the fed-batch
D = 1 culture strategy is effective at expanding clinically relevant
numbers of mature cells, progenitor cells, and LTR-HSCs in224 Cell Stem Cell 10, 218–229, February 3, 2012 ª2012 Elsevier Inca short (12 day) culture time with an automated closed system
bioprocess.
The Fed-Batch Strategy Complements the Effects
of Other of HSC-Enhancing Factors and Provides
Insight into Their Modes of Action
The fed-batch strategy provides a means to assess the effect of
feedback signaling under different conditions and thus serves as
a platform to interrogate the mode of action of factors known to
enhance blood stem and progenitor cell growth (Figure 5A). We
hypothesized that HSC culture additives could be classified into
two major categories depending on whether they act directly on
HSC self-renewal or act indirectly on a mature cell population,
which feeds back positively on HSCs. If the mode of action is
HSC self-renewal specific, the fed-batch strategy should mini-
mize inhibitory feedback signals, providing an enhancing envi-
ronment for HSCs growth. Alternatively, if the mode of action is
non-stem cell autonomous, the fed-batch strategy should dilute
the mature cell population and dilute the soluble signaling mole-
cules that have been produced. In this case, the fed-batch
strategy should reduce the impact of the factor added.
To test this hypothesis, we investigated the interaction
between the fed-batch culture and two known HSC growth-
supportive factors, the aryl hydrocarbon receptor antagonist
(SR1), and the transcription factor HOXB4. SR1 has been shown
to enhance CD34+ and HSC outputs by inhibiting HSC differen-
tiation (Boitano et al., 2010). We thus predicted that the fed-
batch strategy would complement the effect of SR1 by reducing
the impact of endogenous inhibitory feedback signaling. Fig-
ure 5B demonstrates that under our culture conditions, SR1
produced an increase in LTC-IC expansion with both the D = 0
and D = 1 strategy, and the absolute levels of LTC-IC expansion
were significantly enhanced with the D = 1 strategy. Primitive cell
phenotypes were also enhanced with the addition of SR1 (Fig-
ure S5). To validate that this factor was acting directly on a pop-
ulation with a very primitive phenotype and not through a feed-
back-mediated response, we added the molecule to the
LinRholoCD34+CD38CD45RACD49f+ population. Figure 5C
shows that treatment with SR1 leads to a significant increase
in primitive (CD34+CD133+CD90+) cells in this assay, illustrating
that it is directly targeting a population that is highly enriched in
HSCs. Given the apparent additive impact of SR1 and the fed-
batch strategy on the output of primitive cell phenotypes, it is
possible that combining these technologies under the conditions
described herein will enhance the number of LTR-HSCs above
that which has been obtained with the D = 1 strategy alone (Fig-
ure S5). However, because the CD34+CD133+CD90+ phenotype
has not been validated under these culture conditions, limiting
dilution long-term transplantation studies are required to confirm
the potential additive effects between these two technologies.
We next investigated the transcription factor HOXB4, which
has been shown to increase stem and progenitor expansion by
either viral overexpression or delivered as a TAT-HOXB4 soluble
protein (Antonchuk et al., 2002; Csaszar et al., 2009; Krosl et al.,
2003). HOXB4 has been shown to cause increases in the produc-
tion of CD41+megakaryocytes (Zhong et al., 2010), a finding that
we reproduced in our culture system with the TAT-HOXB4
protein (Figure S5). Notably, we have previously reported that
CD41+ cells have a stimulatory feedback effect on LTC-IC.
Figure 4. In Vivo SRC Assay with D = 1 Fed-Batch Strategy Shows an 11-fold Multilineage Expansion of LTR-HSCs
(A) Representative flow cytometry images of bone marrow analysis of (i) nonrepopulated and (ii) repopulated recipient mice. The quantification of the double-
positive quadrant was used to determine the percentage donor contribution for each recipient.
(B and C) Representative images showing multilineage repopulation of recipients, as measured by CD33+, CD19+, GyA+, and CD3+.
(D) Quantification of progenitor cells in repopulated recipient mice.
(E) Representative images of CFCs formed with human cells from repopulated mice.
(F) Limiting dilution curves quantifying LTR-HSC contribution of uncultured (day 0) Lin cells; day 8 cells cultured with the D = 0 strategy; day 8 cells cultured with
the D = 1 strategy; and day 12 cells cultured with the D = 1 strategy. LTR-HSC frequencies corrected to day 0 equivalent cell numbers are indicated for each. Data
are fit with exponential curves.
(G) LTR-HSC expansions were used to calculate SRC numbers, based on 1 3 106 Lin cell input.
Results show the pooled data from two independent experiments. Data are expressed as mean ± 95% CI. See also Tables S1, S2, and S3.
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Figure 5. Fed-Batch System Complements the Effects HSC-Enhancing Molecules and Provides Insight into Their Mode of Action
(A) Schematic of in vitro expansionmode of action. (i) Under base conditions, static (D = 0) culture systems balanceHSC self-renewal and feedback inhibition. The
fed-batch (D = 1) strategy minimizes feedback, while allowing for self-renewal. (ii) The addition of a factor that targets HSC self-renewal gives increased self-
renewal under both D = 0 and D = 1 conditions but the impact will be in enhanced with D = 1 conditions resulting from the reduced feedback. (iii) The addition of
a factor with a positively acting indirect mode of action will increase stimulatory feedback signaling while maintaining self-renewal. Under D = 1 conditions, this
stimulatory feedback will be reduced that will reduce the impact of the added factor.
(B) The addition of the aryl hydrocarbon receptor antagonist (SR1) gives a significant increase in LTC-IC expansion under both D = 0 and D = 1 conditions. n = 5.
(C) When added to a sorted HSC population (LinRholoCD34+CD38CD45RACD49f+), SR1 shows an increase in CD34+CD133+CD90+ numbers. n = 3.
(D) The addition of TAT-HOXB4 yields a significant increase in LTC-IC expansion under D = 0 conditions but not D = 1 conditions, suggesting a non-HSCmode of
action. n = 5.
(E) TAT-HOXB4 shows minimal effect when added to the sorted LinRholoCD34+CD38CD45RACD49f+ population. n = 3.
Data are expressed as mean ± SD. See also Figure S5.
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mode of action of HOXB4 on UCB HSCs was, at least in part, re-
sulting from an indirect feedback-mediated effect, as has also
been suggested in ESC-derived hematopoiesis (Jackson et al.,
2011). As Figure 5D shows, TAT-HOXB4 produced a significant
increase in LTC-ICs when added to D = 0 conditions but the
impact of the molecule was reduced with D = 1 conditions.
Furthermore, TAT-HOXB4 did not produce a significant increase
in expansion when added to LinRholoCD34+CD38CD45RA
CD49f+ cells (Figure 5E). Collectively, these data provide further
insight into the feedback signaling control mechanism that
underpins the HSC-supportive effects of the fed-batch system.
DISCUSSION
A robust strategy to generate ex-vivo-expanded HSCs will
enable the use of UCB for transplantation in patients for whom
a single cord blood unit would not contain the desired progenitor
content and ensure that amuch greater proportion of current and
future banked UCB units are applicable for use by any patient
meeting the HLA matching criteria. In this study, we have com-
putationally interrogated and experimentally validated a highly
tunable hematopoietic progenitor cell expansion strategy that226 Cell Stem Cell 10, 218–229, February 3, 2012 ª2012 Elsevier Inccan produce 11 times more blood stem cells than originally
present over a 12 day culture period. The short culture time
and continuous tight regulation of cell densities also allows this
system to have reduced media volume needs as compared to
other expansion strategies, which is an important feature for
cost-effective clinical implementation. This system has been
designed to be adaptable for direct scale-up to accommodate
cell numbers needed for human transplantations and we are
planning to integrate this technology into clinical trials in the
near future.
The fed-batch strategy relies on simplifying the complexity of
dynamic and heterogeneous hematopoietic culture systems. In
doing so, the need for targeted inhibition of individual endoge-
nously produced factors is eliminated. We have previously
shown evidence that mature hematopoietic cells and their asso-
ciated secreted factors have a net inhibitory effect on stem cell
self-renewal during in vitro culture (Madlambayan et al., 2005).
Strategies to overcome this typically involve a significant amount
of undesired manipulation and handling and provide only a
temporary solution, because undesired factors will quickly reac-
cumulate after each manipulation. Perfusion cultures have been
shown to enhance UCB progenitor cell expansion (Koller et al.,
1998), but these cultures are subject to the challenge of high.
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can be overcome with the use of higher perfusion flow rates,
but this then fails to maintain desired usage limits of media and
cytokines. The fed-batch strategy has the benefit of slowing
the rate of factor accumulation through the continuous dilution
of both endogenous factors and the cells that secrete these
factors.
All current expansion strategies that rely on the direct regula-
tion of the hematopoietic stem and progenitor cell populations
are subject to the unregulated accumulation of inhibitory endog-
enous factors which, if unaccounted for, limit achievable expan-
sion levels. Recent reports of human HSC expansion with appar-
ently stem-cell-autonomous factors include SR1, producing
a 17-fold LTR-HSC expansion (analyzed 16 weeks posttrans-
plantation) after 21 days of in vitro culture, the immobilized Notch
Delta-1 ligand described by Delaney et al. (2010) producing
a 15.6-fold and 6.2-fold in vivo repopulation cell expansion
(analyzed at 3 and 9 weeks posttransplantation, respectively)
after 17–21 days of culture, and the growth factors Angiopoie-
tin-like 5 and IGFBP2 (Zhang et al., 2008), producing a 14-fold
repopulating cell expansion (analyzed at 8 weeks posttransplan-
tation in NOD/SCID recipients) after 10 days of culture. The fed-
batch strategy reported here gives a LTR-HSC expansion of
comparable magnitude with a 12 day culture time and a conser-
vative 16 week posttransplantation analysis. Because this
strategy affects nonautonomous feedback regulation and acts
on the microenvironment of the culture system, it suggests
strong potential to synergize with primarily autonomously acting
expansion strategies, the combinations predicted to lead to
greater and more sustained cell expansions.
It is clear that in vitro (and in vivo) hematopoiesis is dynamic
and regulated, at least in part, through nonlinear feedback
control. The trajectories of factor secretion vary widely among
individual factors and do not always correlate with the expo-
nential trajectory of total cell expansion. Factor concentration
dynamics may follow the dynamics of specific lineage subpop-
ulations or may result from multiple interacting feedback
networks. Moving to nonlinear media dilution strategies is one
example of how more sophisticated dilution dynamics can be
predicted to further tune regulatory interaction and HSC growth
in the system. In order tomaximize this control, a feedback-regu-
lated system in which a set of critical factors is measured, either
‘‘offline’’ by ELISA assay or ‘‘online’’ with the adaption of current
technologies to quantify multiple soluble factors in real-time
(Klostranec et al., 2007), could be linked to a threshold level
process control mechanism. This should allow for the dilution
strategy to be tuned in real-time and would provide a means to
account for sample-to-sample biological variability, ensuring
that optimal expansion can be achieved for each specific cord
blood unit.
The fed-batch strategy is a globally acting expansion strategy
amenable for clinical use, alone or in combination with other
expansion protocols. It also provides a platform with which to
more closely study the dynamic nature of the in vitro hematopoi-
etic cell culture system. We have illustrated how the fed-batch
strategy has different effects when acting in combination with
factors that directly or indirectly enhance HSC growth. These
studies provide insight into the mode of action of the aryl hydro-
carbon receptor antagonist SR1 and the TAT-HOXB4 protein,Cethrough the differing effect that the D = 1 strategy has on
their efficacy. More broadly, they demonstrate that regulating
feedback signaling can act to reduce inhibitory feedback,
thereby allowing factors that target HSC self-renewal to act
with maximal impact.
The ability to modulate secreted factor concentrations and
measure corresponding functional outputs of cell expansions
will allow for a more precise study of links between specific
endogenous protein secretion and lineage subpopulations and
their associated cell-cell interactions. This strategy serves as
a robust clinically relevant system for rapid and automated
in vitro cell expansion as well as a platform for further study of
the regulation of cell-cell interactions in vitro and in vivo.
EXPERIMENTAL PROCEDURES
Mathematical Simulations
The model that we previously developed and described (Kirouac et al., 2009)
was used to run all culture simulations with MATLAB 2009 software (Math-
works, Natick, MA). The model simulates in vitro hematopoietic culture by
incorporating self-renewal and differentiation of cell populations and soluble
factors secreted by mature cells. For this study, the model was adapted to
simulate fed-batch and perfusion strategies by adjusting the rate of change
of secreted factor concentrations. The fed-batch strategy incorporated
a continuous input stream, which resulted in an increase in culture volume
and a dilution of all cells and all endogenously produced secreted factors.
The perfusion strategy included a continuous input and output stream, result-
ing in a constant cell culture volume and a continuous reduction of endoge-
nously produced soluble factors. See Supplemental Experimental Procedures
for details.
Umbilical Cord Blood Cell Collection and Processing
UCB samples were collected from consenting donors according to ethically
approved procedures at Mt. Sinai Hospital (Toronto, ON, Canada). Mononu-
clear cells were obtained as previously described (Kirouac et al., 2009).
Lineage-negative (Lin) progenitor cells were isolated from the mononuclear
cell fraction with the StemSep system or EasySep system with the human
progenitor cell enrichment kit (StemCell Technologies, Inc., Vancouver, BC,
Canada), according to the manufacturer’s protocol.
Cell Seeding and In Vitro Culture
Freshly isolated Lin cells were seeded at an initial density of 13 105 cells/ml in
serum-free IMDM media (GIBCO, Rockville, MD) with 20% BIT serum substi-
tute (StemCell Technologies) and 1%Glutamax (GIBCO). The media was sup-
plemented with 100 ng/ml Stem Cell Factor (SCF, R&D Systems, Minneapolis,
MN), 100 ng/ml FMS-like Trysine Kinase 3 Ligand (FL, R&D Systems), 50 ng/ml
Thrombopoietin (TPO, R&D Systems), and 1 mg/ml low-density lipoproteins
(LDL, Calbiochem, La Jolla, CA). The syringe loaded pumping system was
assembled and connected to the cell culture bag, as previously described
(Csaszar et al., 2009). The initial cell suspension was injected into a 2-port
12 ml culture bag (VueLife, American Fluoroseal Corporation, Gaithersburg,
MD) and maintained on an orbital shaker at 37C and 5% CO2. The pump
was set to deliver the desired volume of media (based on the user-defined
dilution rate) to the cell culture. Media delivery was automated to occur at
0.5 hr intervals at a flow rate of 30 ml/min, for a semicontinuous delivery. For
SR1 studies, SR1 was added to fresh media at 0.75 mM as previously
described (Boitano et al., 2010). For TAT-HOXB4 studies, TAT-HOXB4 was
produced and delivered semicontinuously as previously described (Csaszar
et al., 2009; Krosl et al., 2003).
Cell Assays
Colony-forming cell (CFC) assays and long-term culture-initiating cell
(LTC-IC) assays were performed as previously described (Kirouac et al.,
2009). Surface marker staining was performed with conjugated human
antibodies: CD4, CD7, CD8, CD14, CD19, CD33, CD34, CD38, CD41,
CD49f, CD56, CD90, CD133, and GyA (BD Biosciences, San Jose, CA).ll Stem Cell 10, 218–229, February 3, 2012 ª2012 Elsevier Inc. 227
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tification. All samples were analyzed on a FACSCanto flow cytometer (BD
Biosciences).
Sorted Cell Assay
Freshly isolated Lin cells were sorted for RholoCD34+CD38CD45RA
CD49f+ with a FACSAria flow cytometer (BD Biosciences), according to the
gating strategy previously described (Notta et al., 2011). 40 sorted cells
were dispensed per well in a 96-well plate in the above-described media
and cultured for 7 days. After culture, cells were assessed for total cell number
and number of CD34+CD133+CD90+ cells by flow cytometry.
Limiting Dilution Transplantation Studies
All animal studies were performed according to procedures approved by
appropriate animal ethics boards. Female NSG mice were sublethally irradi-
ated (250 rad) <24 hr before transplantation. Uncultured Lin cells (n = 26) or
cells cultured for 8 days (n = 50) or 12 days (n = 25) were transplanted at limiting
dilution via tail vein injection. Mice were sacrificed 16 weeks after transplanta-
tion and bone marrow was collected from femurs and tibias. Cells were
assessed by flow cytometry. Mice were scored positive for human repopula-
tion if at least 0.5% of bone marrow cells were positive for both human
CD45 and human HLA-ABC. For secondary transplantations, 33% of the
harvested bone marrow cells of positively engrafted mice were transplanted
into secondary NSG recipients. Bone marrow harvest and analysis was
performed after 16 weeks. All limiting dilution analysis was performed with
the L-calc software (StemCell Technologies, Inc.). Limiting dilution anal-
ysis was based on the combined data of two independent transplantation
studies.
Secreted Factor Analysis
Secreted factor concentrations were sampled in duplicate from conditioned
media samples using the Human Cytokine 30-Plex panel (Invitrogen, Burling-
ton, ON, Canada), designed for the Luminex microsphere detection platform
(Luminex Co. Austin, TX), to screen for EGF, Eotaxin, FGF-b, G-CSF, GM-CSF,
HGF, IFN-a, IFN-g, IL-1b, IL-IRA, IL-2, IL-2R, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10,
IL-12, IL-13, IL-15, IL-17, IP-10 (CXCL10), MCP-1 (CCL2), MIG (CLCL9),
MIP-1a (CCL3), MIP-1b (CCL4), RANTES (CCL5), TNF-a, and VEGF. Samples
were prepared and assessed with a BD FACSCanto flow cytometer, as
previously described (Kirouac et al., 2009). TGF-b1 was analyzed separately
in parallel, with a TGF-b1 Quantikine ELISA Kit (R&D Systems, Minneapolis,
MN), according to the manufacturer’s directions.
Glucose and Lactate Assay
Conditionedmedia samples were analyzed for glucose levels, with the Amplex
Red Glucose/Glucose Oxidase Assay kit (Invitrogen), according to the manu-
facturer’s protocol. In the subsequent glucose normalization study, D-glucose
was added to the D = 0 cell culture media every 2 days. Lactate concentrations
were analyzed with a L-lactate assay kit (Eton Bioscience, San Diego, CA),
according to the manufacturer’s protocol.
Statistical Analysis
Statistical significance was computed via a Student’s t test. All error bars
represent the standard deviation of three or more biological replicates. Aster-
isks indicate statistical significance between conditions of p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
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